» Articles » PMID: 2322649

Distribution of Estrogen and Progesterone Receptors in Healthy Tissue Adjacent to Breast Lesions at Various Stages--immunohistochemical Study of 107 Cases

Overview
Specialty Oncology
Date 1990 Feb 1
PMID 2322649
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this study was to determine the distribution of ER+ (estrogen receptor) and PR+ (progesterone receptor) epithelial cells in normal mammary tissue or in tissue in contact with or involved in benign or malignant processes. Three important findings emerged from this study. First, a true dissociation was observed between ER+ and PR+ cells in mammary tissue. In premenopausal women some cells express only progesterone receptors. In premenopausal normal tissue, regardless of the menstrual cycle status, 6% of cells are ER+ and 29% PR+. Second, during the menstrual cycle the percentage of positive cells varies. This finding would indicate a change in cell recruitment rather than in intracellular levels. Finally, specific changes in the proportion of positive cells in normal tissue in contact with epithelial proliferations were noted. This finding suggests the possibility of either a diffusible factor or a cellular pathological process spreading beyond areas displaying morphological changes.

Citing Articles

Morphological Features and Immunohistochemical Profiling of Male Breast Gynaecomastia; A Large Tissue Microarray Study.

Prasad P, Bennett A, Speirs V, Shaaban A Front Oncol. 2022; 12:875839.

PMID: 35814372 PMC: 9261459. DOI: 10.3389/fonc.2022.875839.


Investigating the Factors Associated with the Level of Expression of Estrogen and Progesterone Receptors in Patients Suffering from Colorectal Cancer.

Salehi Far S, Soltani M, Zardast M, Ghasemian Moghaddam M J Cancer Epidemiol. 2021; 2021:4478155.

PMID: 34691180 PMC: 8536452. DOI: 10.1155/2021/4478155.


Protein arginine N-methyltransferase 2 reverses tamoxifen resistance in breast cancer cells through suppression of ER-α36.

Shen Y, Zhong J, Liu J, Liu K, Zhao J, Xu T Oncol Rep. 2018; 39(6):2604-2612.

PMID: 29620287 PMC: 5983932. DOI: 10.3892/or.2018.6350.


Breast cancer risk factors in relation to estrogen receptor, progesterone receptor, insulin-like growth factor-1 receptor, and Ki67 expression in normal breast tissue.

Oh H, Eliassen A, Beck A, Rosner B, Schnitt S, Collins L NPJ Breast Cancer. 2017; 3:39.

PMID: 28979927 PMC: 5624935. DOI: 10.1038/s41523-017-0041-7.


Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast Cancer.

Danforth Jr D Breast Cancer (Auckl). 2016; 10:109-46.

PMID: 27559297 PMC: 4990153. DOI: 10.4137/BCBCR.S39384.


References
1.
Jacquemier J, Rolland P, Vague D, LIEUTAUD R, Spitalier J, Martin P . Relationships between steroid receptor and epithelial cell proliferation in benign fibrocystic disease of the breast. Cancer. 1982; 49(12):2534-6. DOI: 10.1002/1097-0142(19820615)49:12<2534::aid-cncr2820491221>3.0.co;2-j. View

2.
Horwitz K, McGuire W . Predicting response to endocrine therapy in human breast cancer: a hypothesis. Science. 1975; 189(4204):726-7. DOI: 10.1126/science.168640. View

3.
Clark G, McGuire W . Prognostic factors in primary breast cancer. Breast Cancer Res Treat. 1983; 3 Suppl:S69-72. DOI: 10.1007/BF01855130. View

4.
Fabbro D, Kung W, ROOS W, Regazzi R, Eppenberger U . Epidermal growth factor binding and protein kinase C activities in human breast cancer cell lines: possible quantitative relationship. Cancer Res. 1986; 46(6):2720-5. View

5.
Nicholson S, Sainsbury J, Needham G, Chambers P, Farndon J, Harris A . Quantitative assays of epidermal growth factor receptor in human breast cancer: cut-off points of clinical relevance. Int J Cancer. 1988; 42(1):36-41. DOI: 10.1002/ijc.2910420108. View